[1]
|
World Health Organization (2018) World Malaria Report.
|
[2]
|
Organisation mondiale de la Santé (2014) Statistiques Sanitaires mondiales.
|
[3]
|
WHO (2017) World Malaria Report 2017.
|
[4]
|
Organisation mondiale de la Santé (2017) Résistance aux médicaments antipaludiques.
|
[5]
|
Amor, A., Toro, C., Fernandez-Martinez, A., Baquero, M., Benito, A. and Berzosa, P. (2012) Molecular Markers in Plasmodium falciparum Linked to Resistance to Anti-Malarial Drugs in Samples Imported from Africa over an Eight-Year Period (2002-2010): Impact of the Introduction of Artemisinin Combination Therapy. Malaria Journal, 11, 100. https://doi.org/10.1186/1475-2875-11-100
|
[6]
|
Ménard, D., Khim, N., Beghain, J., Adegnika, A.A., Shafiul-Alam, M., Amodu, O., et al. (2016) A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. New England Journal of Medicine, 374, 2453-2464. https://doi.org/10.1056/NEJMoa1513137
|
[7]
|
Kamau, E., Campino, S., Amenga-Etego, L., Drury, E., Ishengoma, D., Johnson, K., et al. (2014) K13-Propeller Polymorphisms in Plasmodium falciparum Parasites from Sub-Saharan Africa. Journal of Infectious Diseases, 211, 1352-1355. https://doi.org/10.1093/infdis/jiu608
|
[8]
|
Somé, A.F., Sorgho, H., Zongo, I., Bazié, T., Nikiéma, F., Sawadogo, A., et al. (2016) Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in Parasites Isolated from Symptomatic Malaria Patients in Burkina Faso. Parasite (Paris, France), 23, 60. https://doi.org/10.1051/parasite/2016069
|
[9]
|
Oguike, M.C., Falade, C.O., Shu, E., Enato, I.G., Watila, I., Baba, E.S., et al. (2016) Molecular Determinants of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum in Nigeria and the Regional Emergence of dhps 431V. International Journal for Parasitology. Drugs and Drug Resistance, 6, 220-229. https://doi.org/10.1016/j.ijpddr.2016.08.004
|
[10]
|
Cisse, M., Awandare, G.A., Soulama, A., Tinto, H., Hayette, M.-P. and Guiguemdé, R.T. (2017) Recent Uptake of Intermittent Preventive Treatment during Pregnancy with Sulfadoxine-Pyrimethamine Is Associated with Increased Prevalence of Pfdhfr Mutations in Bobo-Dioulasso, Burkina Faso. Malaria Journal, 16, 38. https://doi.org/10.1186/s12936-017-1695-1
|
[11]
|
Basco, L.K., Tahar, R., Ako, A.B., Djaman, J.A., Roman, J., Ngane, V.F., et al. (2017) Molecular Epidemiology of Malaria in Cameroon and Cote d’Ivoire. XXXI. Kelch 13 Propeller Sequences in Plasmodium falciparum Isolates before and after Implementation of Artemisinin-Based Combination Therapy. The American Journal of Tropical Medicine and Hygiene, 97, 222-224. https://doi.org/10.4269/ajtmh.16-0889
|
[12]
|
Basco, L.K. and Ringwald, P. (2000) Molecular Epidemiology of Malaria in Yaounde, Cameroon. VI. Sequence Variations in the Plasmodium falciparum Dihydrofolate Reductase-Thymidylate Synthase Gene and in Vitro Resistance to Pyrimethamine and Cycloguanil. American Journal of Tropical Medicine and Hygiene, 62, 271-276. https://doi.org/10.4269/ajtmh.2000.62.271
|
[13]
|
World Health Organization (2012) World Malaria Report.
|
[14]
|
Douamba, Z., Bisseye, C., Djigma, F.W., Compaor, T.R., Bazie, T., Pietra, V., et al. (2012) Asymptomatic Malaria Correlates with Anaemia in Pregnant Women at Ouagadougou, Burkina Faso. Journal of Biomedicine and Biotechnology, 2012, Article ID: 198317. https://doi.org/10.1155/2012/198317
|
[15]
|
Yameogo, N., Valérie, B., Jean, E., Bazie, T., Ouattara, A.K., Yameogo, P., et al. (2017) Major Polymorphisms of Genes Involved in Homocysteine Metabolism in Malaria Patients in Ouagadougou, Burkina Faso. Malaria Research and Treatment, 2017, Article ID: 3468276. https://doi.org/10.1155/2017/3468276
|
[16]
|
Pierre Aubry, B.-A.G. (2017) Paludisme [Internet]. Medecine Tropicale. 1-27. http://www.medecinetropicale.com%0A1
|
[17]
|
Douamba, Z., Ginette, N., Dao, L., Zohoncon, T.M., Bisseye, C., Compaoré, T.R., et al. (2014) Research Article Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso. Malaria Research and Treatment, 2014, Article ID: 390513. https://doi.org/10.1155/2014/390513
|
[18]
|
World Health Organization (2010) Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010.
|
[19]
|
Bruneton, J. (2009) Pharmacognosie Phytochimie Plantes médicinales. 4th Editions.
|
[20]
|
Chekem, L. and Wierucki, S. (2007) Extraction de l’artémisinine et synthèse de ses dérivés: Artésunate et artéméther. Phytothérapie, 5, 90-95. https://doi.org/10.1007/s10298-007-0218-6
|
[21]
|
Artémisinine [Internet]. Wikipédia, l’encyclopédie libre, 2018. https://fr.wikipedia.org/wiki/Art%C3%A9misinine#/m https://fr.wikipedia.org/wiki/Artémisinine Http://fr.wikipedia.org/w/index.php?title=Art%C3%A9misinine&action=history
|
[22]
|
Cooper, R.A., Conrad, M.D., Watson, Q.D., Huezo, S.J., Ninsiima, H., Tumwebaze, P., et al. (2015) Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays. Antimicrobial Agents and Chemotherapy, 59, 5061-5064. https://doi.org/10.1128/AAC.00921-15
|
[23]
|
Isozumi, R., Uemura, H., Kimata, I., Ichinose, Y., Logedi, J., Omar, A.H., et al. (2015) Novel Mutations in K13 Propeller Gene of Artemisinin-Resistant Plasmodium falciparum. Emerging Infectious Diseases, 21, 490-492. https://doi.org/10.3201/eid2103.140898
|
[24]
|
Ouattara, A., Kone, A., Adams, M., Fofana, B., Maiga, A.W., Hampton, S., et al. (2015) Polymorphisms in the K13-Propeller Gene in Artemisinin-Susceptible Plasmodium falciparum Parasites from Bougoula-Hameau and Bandiagara, Mali. The American Journal of Tropical Medicine and Hygiene, 92, 1202-1206. https://doi.org/10.4269/ajtmh.14-0605
|
[25]
|
Straimer, J., Gnadig, N.F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A.P., et al. (2015) K13-Propeller Mutations Confer Artemisinin Resistance in Plasmodium falciparum Clinical Isolates. Science, 347, 428-431. https://doi.org/10.1126/science.1260867
|
[26]
|
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., et al. (2014) A Molecular Marker of Artemisinin-Resistant Plasmodium falciparum Malaria. Nature, 505, 50-55. https://doi.org/10.1038/nature12876
|
[27]
|
Phompradit, P., Chaijaroenkul, W. and Na-Bangchang, K. (2017) Cellular Mechanisms of Action and Resistance of Plasmodium falciparum to Artemisinin. Parasitology Research, 116, 3331-3339. https://doi.org/10.1007/s00436-017-5647-z
|
[28]
|
World Health Organization (2018) Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy.
|
[29]
|
Das, D., Price, R.N., Bethell, D., Guerin, P.J. and Stepniewska, K. (2013) Early Parasitological Response Following Artemisinin-Containing Regimens: A Critical Review of the Literature. Malaria Journal, 12, 125. https://doi.org/10.1186/1475-2875-12-125
|
[30]
|
Sugawara, E. and Nikaido, H. (2014) Status Report on Artemisinin and ACT Resistance. Antimicrobial Agents and Chemotherapy, 58, 7250-7257. https://doi.org/10.1128/AAC.03728-14
|
[31]
|
Higgins, J.P.T. and Green, S. (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. The Cochrane Library.
|
[32]
|
London School of Hygiene and Tropical Medicine (2010) Drugs Resistance Maps (Mapping the Distribution of Resistance Genes of Malaria in Africa) [Internet]. Drug Resistance Maps. http://www.drugresistancemaps.org/maps/haplotype/dhfr
|
[33]
|
Ogouyemi-Hounto, A., Ndam, N.T., Kinde Gazard, D., d’Almeida, S., Koussihoude, L., Ollo, E., et al. (2013) Prevalence of the Molecular Marker of Plasmodium falciparum Resistance to Chloroquine and Sulphadoxine/Pyrimethamine in Benin Seven Years after the Change of Malaria Treatment Policy. Malaria Journal, 12, 147. https://doi.org/10.1186/1475-2875-12-147
|
[34]
|
Nahum, A., Erhart, A., Ahounou, D., Bonou, D., Van Overmeir, C., Menten, J., et al. (2009) Extended High Efficacy of the Combination Sulphadoxine-Pyrimethamine with Artesunate in Children with Uncomplicated Falciparum Malaria on the Benin Coast, West Africa. Malaria Journal, 8, 37. https://doi.org/10.1186/1475-2875-8-37
|
[35]
|
Ndiaye, D., Dieye, B., Ndiaye, Y.D., Tyne, D., Daniels, R., Bei, A.K., et al. (2013) Polymorphism in dhfr/dhps Genes, Parasite Density and ex Vivo Response to Pyrimethamine in Plasmodium falciparum Malaria Parasites in Thies, Senegal. International Journal for Parasitology: Drugs and Drug Resistance, 3, 135-142. https://doi.org/10.1016/j.ijpddr.2013.07.001
|
[36]
|
Moussiliou, A., De Tove, Y.S.-S., Doritchamou, J., Luty, A.J.F., Massougbodji, A., Alifrangis, M., et al. (2013) High Rates of Parasite Recrudescence Following Intermittent Preventive Treatment with Sulphadoxine-Pyrimethamine during Pregnancy in Benin. Malaria Journal, 12, 195. https://doi.org/10.1186/1475-2875-12-195
|
[37]
|
Taylor, S.M., Parobek, C.M., DeConti, D.K., Kayentao, K., Coulibaly, S.O., Greenwood, B.M., et al. (2015) Absence of Putative Artemisinin Resistance Mutations among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study. The Journal of Infectious Diseases, 211, 680-688. https://doi.org/10.1093/infdis/jiu467
|
[38]
|
Dieye, B., Affara, M., Sangare, L., Joof, F., Ndiaye, Y.D., Gomis, J.F., et al. (2016) West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and the Gambia. The American Journal of Tropical Medicine and Hygiene, 95, 1054-1060. https://doi.org/10.4269/ajtmh.16-0053
|
[39]
|
Boussaroque, A., Fall, B., Madamet, M., Camara, C., Benoit, N., Fall, M., et al. (2016) Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013-2014. Antimicrobial Agents and Chemotherapy, 60, 624-627. https://doi.org/10.1128/AAC.01346-15
|
[40]
|
Dorkenoo, A.M., Yehadji, D., Agbo, Y.M., Layibo, Y., Agbeko, F., Adjeloh, P., et al. (2016) Therapeutic Efficacy Trial of Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria and Investigation of Mutations in k13 Propeller Domain in Togo, 2012-2013. Malaria Journal, 15, 331. https://doi.org/10.1186/s12936-016-1381-8
|
[41]
|
Doumbo, S., Ongoiba, O.A., Doumtabe, D., Dara, A., Ouologuem, T.D., Kayentao, K., et al. (2013) Prevalence of Plasmodium falciparum, Anemia and Molecular Markers of Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Delivered Women in Fana, Mali. Bulletin de la Societe de pathologie exotique (1990), 106, 188-192. https://doi.org/10.1007/s13149-013-0301-1
|
[42]
|
Kublin, J.G., Dzinjalamala, F.K., Kamwendo, D.D., Malkin, E.M., Cortese, J.F., Martino, L.M., et al. (2002) Molecular Markers for Failure of Sulfadoxine-Pyrimethamine and Chlorproguanil-Dapsone Treatment of Plasmodium falciparum Malaria. The Journal of Infectious Diseases, 185, 380-388. https://doi.org/10.1086/338566
|
[43]
|
Duah, N.O., Quashie, N.B., Abuaku, B.K., Sebeny, P.J., Kronmann, K.C. and Koram, K.A. (2012) Surveillance of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine 5 Years after the Change of Malaria Treatment Policy in Ghana. The American Journal of Tropical Medicine and Hygiene, 87, 996-1003. https://doi.org/10.4269/ajtmh.2012.12-0202
|
[44]
|
Méndez, F., Munoz, A., Carrasquilla, G., Jurado, D., Arévalo-Herrera, M. and Cortese, J.F. (2002) Determinants of Treatment Response to Sulfadoxine-Pyrimethamine and Subsequent Transmission Potential in Falciparum Malaria. American Journal Epidemiology, 156, 230-238. https://doi.org/10.1093/aje/kwf030
|
[45]
|
Tahita, M.C., Tinto, H., Erhart, A., Kazienga, A., Fitzhenry, R., VanOvermeir, C., et al. (2015) Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine. PLoS ONE, 10, e0137440. https://doi.org/10.1371/journal.pone.0137440
|
[46]
|
Ogouyèmi-Hounto, A., Ndam, N.T., Fadégnon, G., Azagnandji, C., Bello, M., Moussiliou, A., et al. (2013) Low Prevalence of the Molecular Markers of Plasmodium falciparum Resistance to Chloroquine and Sulphadoxine/Pyrimethamine in Asymptomatic Children in Northern Benin. Malaria Journal, 12, 413. https://doi.org/10.1186/1475-2875-12-413
|
[47]
|
Wurtz, N., Fall, B., Pascual, A., Diawara, S., Sow, K., Baret, E., et al. (2012) Prevalence of Molecular Markers of Plasmodium falciparum Drug Resistance in Dakar, Senegal. Malaria Journal, 11, 197. https://doi.org/10.1186/1475-2875-11-197
|
[48]
|
Fabrice, S.A., Zongo, I., Rouamba, N., Compaore, Y.D., Dokomajilar, C., Rosenthal, P.J., et al. (2011) Plasmodium falciparum Drug Resistance Molecular Markers under Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine (DP) vs. Amodiaquine-Sulfadoxine/Pyrimethamine (AQ-SP) in Burkina Faso. American Journal of Tropical Medicine and Hygiene, 85, 361.
|
[49]
|
Faye, B., Ndiaye, M., Ndiaye, J.L., Annie, A., Tine, R.C., Lo, A.C., et al. (2011) Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulfadoxine-Pyrimethamine during the Intermittent Preventive Treatment in Infants Coupled with the Expanded Program Immunization in Senegal. Parasitology Research, 109, 133-138. https://doi.org/10.1007/s00436-010-2236-9
|
[50]
|
Alam, M.T., de Souza, D.K., Vinayak, S., Griffing, S.M., Poe, A.C., Duah, N.O., et al. (2011) Selective Sweeps and Genetic Lineages of Plasmodium falciparum Drug-Resistant Alleles in Ghana. The Journal of Infectious Diseases, 203, 220-227. https://doi.org/10.1093/infdis/jiq038
|
[51]
|
Djaman, J.A., Mazabraud, A. and Basco, L. (2007) Sulfadoxine-Pyrimethamine Susceptibilities and Analysis of the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum Isolates from Cote d’Ivoire. Annals of Tropical Medicine and Parasitology, 101, 103-112. https://doi.org/10.1179/136485907X154584
|
[52]
|
Ruizendaal, E., Tahita, M.C., Geskus, R.B., Versteeg, I., Scott, S., d’Alessandro, U., et al. (2017) Increase in the Prevalence of Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum Isolates Collected from Early to Late Pregnancy in Nanoro, Burkina Faso. Malaria Journal, 16, 179. https://doi.org/10.1186/s12936-017-1831-y
|